Earlier this month I wrote a piece on Field Trip (FTRP.C) scaling their ketamine clinics after a huge $95M raise. I liked their business model, and Novamind’s (NM.C) is similar, but with a much smaller market cap. Novamind has two main divisions, clinics and research. The company provides ketamine-assisted psychotherapy and other novel treatments through … Continue reading Novamind (NM.C) putting up some serious revenue for an early stage psychedelics company